Skip to main content

Hyperfine to Present at the Piper Sandler 38th Annual Healthcare Conference on December 3

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain—the Swoop® system—today announced that management will present at the Piper Sandler 38th Annual Healthcare Conference in New York on Thursday, December 3, 2026 at 9:10 a.m. Eastern Time. Management will also host in-person investor meetings at the conference.

A live webcast, as well as an archived recording, will be available on the “Investors” section of the Company’s website at: https://investors.hyperfine.io/. The webcast will be archived and available for replay for at least 90 days after the event.

To schedule a one-on-one meeting with Hyperfine management, please reach out to your Piper Sandler representative, or the investor contact below.

About the Swoop® Portable MRI Systems

The Swoop® Portable MR Imaging® Systems are U.S. Food and Drug Administration (FDA) cleared for brain imaging of patients of all ages. They are portable, ultra-low-field magnetic resonance imaging devices for producing images that display the internal structure of the head where full diagnostic examination is not clinically practical. When interpreted by a trained physician, these images provide information that can be useful in determining a diagnosis.

About Hyperfine, Inc.

Hyperfine, Inc. (Nasdaq: HYPR) is the groundbreaking health technology company that has redefined brain imaging with the Swoop® system—the first FDA-cleared, portable, ultra-low-field, magnetic resonance brain imaging system capable of providing imaging at multiple points of professional care. The mission of Hyperfine, Inc. is to revolutionize patient care globally through transformational, accessible, clinically relevant diagnostic imaging. Founded by Dr. Jonathan Rothberg in a technology-based incubator called 4Catalyzer, Hyperfine, Inc. scientists, engineers, and physicists developed the Swoop® system out of a passion for redefining brain imaging methodology and how clinicians can apply accessible diagnostic imaging to patient care. For more information, visit HyperfineMRI.com.

The Hyperfine logo, Swoop, and Portable MR Imaging are registered trademarks of Hyperfine, Inc. The Swoop logo, Optive AI logo, and Optive AI are trademarks of Hyperfine, Inc.

Contacts

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  257.37
-10.37 (-3.87%)
AAPL  349.21
-3.24 (-0.92%)
AMD  489.19
-40.95 (-7.72%)
BAC  48.57
-0.34 (-0.70%)
GOOG  271.02
-8.18 (-2.93%)
META  596.22
-20.16 (-3.27%)
MSFT  498.30
-9.99 (-1.97%)
NVDA  145.98
-4.98 (-3.30%)
ORCL  110.57
-3.32 (-2.92%)
TSLA  374.41
-9.31 (-2.43%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.